- Home
- ABVC vs CCM Comparison
ABVC vs CCM Comparison
Compare ABVC & CCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABVC
- CCM
- Stock Information
- Founded
- ABVC 2015
- CCM 1997
- Country
- ABVC United States
- CCM China
- Employees
- ABVC N/A
- CCM N/A
- Industry
- ABVC Biotechnology: Pharmaceutical Preparations
- CCM Medical/Nursing Services
- Sector
- ABVC Health Care
- CCM Health Care
- Exchange
- ABVC Nasdaq
- CCM Nasdaq
- Market Cap
- ABVC 16.7M
- CCM 18.2M
- IPO Year
- ABVC N/A
- CCM 2009
- Fundamental
- Price
- ABVC $1.33
- CCM $7.71
- Analyst Decision
- ABVC
- CCM
- Analyst Count
- ABVC 0
- CCM 0
- Target Price
- ABVC N/A
- CCM N/A
- AVG Volume (30 Days)
- ABVC 213.2K
- CCM 70.5K
- Earning Date
- ABVC 04-30-2025
- CCM 05-16-2025
- Dividend Yield
- ABVC N/A
- CCM N/A
- EPS Growth
- ABVC N/A
- CCM N/A
- EPS
- ABVC N/A
- CCM N/A
- Revenue
- ABVC $508,383.00
- CCM $52,603,198.00
- Revenue This Year
- ABVC $735.18
- CCM N/A
- Revenue Next Year
- ABVC N/A
- CCM N/A
- P/E Ratio
- ABVC N/A
- CCM N/A
- Revenue Growth
- ABVC 1904.43
- CCM N/A
- 52 Week Low
- ABVC $0.40
- CCM $3.80
- 52 Week High
- ABVC $1.40
- CCM $26.70
- Technical
- Relative Strength Index (RSI)
- ABVC 71.45
- CCM 66.51
- Support Level
- ABVC $1.01
- CCM $6.18
- Resistance Level
- ABVC $1.00
- CCM $10.00
- Average True Range (ATR)
- ABVC 0.09
- CCM 1.17
- MACD
- ABVC 0.03
- CCM 0.17
- Stochastic Oscillator
- ABVC 92.78
- CCM 56.98
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.